Want to see NNVC full AI Analyst Report?
NanoViricides (NNVC) Stock Statistics & Valuation Metrics
Total Valuation
NanoViricides has a market cap or net worth of $33.69M. The enterprise value is $23.30M.
- Market Cap
- $33.69M
- Enterprise Value
- $23.30M
Share Statistics
NanoViricides has 25,525,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 25,525,000
- Owned by Insiders
- ―
- Owned by Institutions
- 8.78%
Financial Efficiency
NanoViricides’s return on equity (ROE) is -0.95 and return on invested capital (ROIC) is -95.66%.
- Return on Equity (ROE)
- -0.95
- Return on Assets (ROA)
- -0.83
- Return on Invested Capital (ROIC)
- -95.66%
- Return on Capital Employed (ROCE)
- -0.96
- Revenue Per Employee
- 0
- Profits Per Employee
- -1.17M
- Employee Count
- 7
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of NanoViricides is -3.23. NanoViricides’s PEG ratio is -0.07.
- PE Ratio
- -3.23
- PS Ratio
- 0.00
- PB Ratio
- 3.09
- Price to FCF
- -4.36
- Price to Operating Cash Flow
- -3.49
- PEG Ratio
- -0.07
Income Statement
In the last 12 months, NanoViricides had revenue of 0 and earned -8.22M in profits. Earnings per share was -0.41.
- Revenue
- 0
- Gross Profit
- -525.29K
- Operating Income
- -8.31M
- Pretax Income
- -8.22M
- Net Income
- -8.22M
- EBITDA
- -7.78M
- Earnings Per Share (EPS)
- -0.41
Cash Flow
In the last 12 months, operating cash flow was 3.12T and capital expenditures 84.32B, giving a free cash flow of 3.20T billion.
- Operating Cash Flow
- 3.12T
- Free Cash Flow
- 3.20T
- Free Cash Flow per Share
- -0.39
Dividends & Yields
NanoViricides pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -22.66%
- Earnings Yield
- -30.27%
Stock Price Statistics
- Beta
- 0.95
- 52-Week Price Change
- -30.53%
- 50-Day Moving Average
- 1.32
- 200-Day Moving Average
- 1.29
- Relative Strength Index (RSI)
- 46.81
- Average Volume (3m)
- 380.73K
Important Dates
NanoViricides upcoming earnings date is Nov 23, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Nov 24, 2025
- Next Earnings Date
- Nov 23, 2026
- Ex-Dividend Date
- ―
Financial Position
NanoViricides as a current ratio of 2.66, with Debt / Equity ratio of 0.00%
- Current Ratio
- 2.66
- Quick Ratio
- 2.66
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.36
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, NanoViricides has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
NanoViricides EV to EBITDA ratio is -4.09, with an EV/FCF ratio of -4.05.
- EV to Sales
- 0.00
- EV to EBITDA
- -4.09
- EV to Free Cash Flow
- -4.05
- EV to Operating Cash Flow
- -4.10
Balance Sheet
NanoViricides has $2.79M in cash and marketable securities with $0.00 in debt, giving a net cash position of $2.79M billion.
- Cash & Marketable Securities
- $2.79M
- Total Debt
- $0.00
- Net Cash
- $2.79M
- Net Cash Per Share
- $0.11
- Tangible Book Value Per Share
- $0.41
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for NanoViricides is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $6.00
- Price Target Upside
- 354.55% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 35.47%
Scores
- Smart Score
- 3
- AI Score
- 46
